Clinical Trial Update: Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients [Phase 1]

View source ↗

Summary

Phase I/II study evaluating AZD2171 in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer; the trial status is ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZD2171 (cediranib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: TERMINATED